نتائج البحث

Local Recurrence Following Resection of Intermediate-High Risk Nonmetastatic Renal Cell Carcinoma: An Anatomical Classification and Analysis of the ASSURE (ECOG-ACRIN E2805) Adjuvant Trial.

• Authors : Lee, Ziho; Jegede, Opeyemi A; Haas, Naomi B

Subjects: Biomedical and Clinical Sciences; Clinical Sciences; Oncology and Carcinogenesis

• Source: Investigative Urology. 203(4)

تفاصيل العنوان

Retroperitoneal Lymphadenectomy for High Risk, Nonmetastatic Renal Cell Carcinoma: An Analysis of the ASSURE (ECOG-ACRIN 2805) Adjuvant Trial

• Authors : Ristau, Benjamin T; Manola, Judi; Haas, Naomi B

Subjects: Biomedical and Clinical Sciences; Clinical Sciences; Oncology and Carcinogenesis

• Source: Investigative Urology. 199(1)

تفاصيل العنوان

Primary therapy with single agent bortezomib as induction, maintenance and re-induction in patients with high-risk myeloma: results of the ECOG E2A02 trial.

• Authors : Dispenzieri A; Department of Hematology, Mayo Clinic, Rochester, MN 55905, USA. ; Jacobus S

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Boronic Acids/Boronic Acids/Boronic Acids/*therapeutic use ; Multiple Myeloma/Multiple Myeloma/Multiple Myeloma/*drug therapy

• Source: Leukemia [Leukemia] 2010 Aug; Vol. 24 (8), pp. 1406-11. Date of Electronic Publication: 2010 Jun 10.Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

A randomized phase II trial of mitoxantrone, estramustine and vinorelbine or bcl-2 modulation with 13-cis retinoic acid, interferon and paclitaxel in patients with metastatic castrate-resistant prostate cancer: ECOG 3899.

• Authors : DiPaola RS; Department of Medicine, The Cancer Institute of New Jersey, UMDNJ-RWJMS, New Brunswick NJ, USA. ; Chen YH

Subjects: Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/drug therapy ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/mortality ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/pathology

• Source: Journal of translational medicine [J Transl Med] 2010 Feb 24; Vol. 8, pp. 20. Date of Electronic Publication: 2010 Feb 24.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

تفاصيل العنوان

Tolerability of intensified intravenous interferon alfa-2b versus the ECOG 1684 schedule as adjuvant therapy for stage III melanoma: a randomized phase III Italian Melanoma Inter-group trial (IMI - Mel.A.) [ISRCTN75125874].

• Authors : Chiarion-Sileni V; Department of Medical Oncology, University Hospital, Padua, Italy. ; Del Bianco P

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*administration & dosage ; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*adverse effects ; Interferon-alpha/Interferon-alpha/Interferon-alpha/*administration & dosage

• Source: BMC cancer [BMC Cancer] 2006 Feb 27; Vol. 6, pp. 44. Date of Electronic Publication: 2006 Feb 27.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer.

• Authors : Forrest LM; University Department of Surgery, Royal Infirmary, Glasgow G31 2ER, Scotland, UK.; McMillan DC

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*blood ; Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/*mortality

• Source: British journal of cancer [Br J Cancer] 2004 May 04; Vol. 90 (9), pp. 1704-6.Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print Cited Medium:

تفاصيل العنوان

Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial

• Authors : Wakelee, Heather A; Dahlberg, Suzanne E; Keller, Steven M

Subjects: Clinical Research; Lung Cancer; Lung

• Source: The Lancet Oncology. 18(12)

تفاصيل العنوان

MicroRNA expression profiling predicts clinical outcome of carboplatin/paclitaxel-based therapy in metastatic melanoma treated on the ECOG-ACRIN trial E2603.

• Authors : Villaruz, Liza C.¹; Huang, Grace²; Romkes, Marjorie¹

• Source: Clinical Epigenetics. 2015, Vol. 7 Issue 1, p1-9. 9p.

تفاصيل العنوان

Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer

• Authors : Wilson J. Angerson; L M Forrest; Donald C. McMillan

Subjects: Adult; Male; Oncology

• Source: British Journal of Cancer

تفاصيل العنوان

Primary therapy with single agent bortezomib as induction, maintenance and re-induction in patients with high-risk myeloma: results of the ECOG E2A02 trial

• Authors : Susanna Jacobus; Angela Dispenzieri; Natalie Callandar

Subjects: Oncology; Adult; Male

• Source: Leukemia

تفاصيل العنوان